Jin Ma Selected Research

Doxorubicin (Adriamycin)

12/2018	Detachable Polyzwitterion-Coated Ternary Nanoparticles Based on Peptide Dendritic Carbon Dots for Efficient Drug Delivery in Cancer Therapy.
12/2017	Localized drug release and effective chemotherapy by hyperthermia-governed bubble-generating hybrid nanocapsule system.
4/2015	A let-7b binding site SNP in the 3'-UTR of the Bcl-xL gene enhances resistance to 5-fluorouracil and doxorubicin in breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jin Ma Research Topics

Disease

27	Neoplasms (Cancer) 04/2024 - 10/2006
19	Inflammation (Inflammations) 06/2023 - 03/2011
18	Fibrosis (Cirrhosis) 01/2023 - 07/2011
12	Myocardial Infarction 10/2023 - 07/2011
9	Ischemic Stroke 02/2024 - 01/2015
9	Nasal Polyps (Nasal Polyp) 01/2023 - 02/2016
8	Hypoxia (Hypoxemia) 02/2024 - 11/2011
8	Atrial Fibrillation 07/2022 - 01/2018
7	Heart Failure 01/2022 - 07/2011
6	Reperfusion Injury 01/2024 - 12/2008
6	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023 - 01/2014
6	Polyps 01/2021 - 06/2015
5	Lung Neoplasms (Lung Cancer) 04/2024 - 02/2019
5	Ischemia 04/2024 - 12/2008
5	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 06/2023 - 01/2021
5	Stroke (Strokes) 01/2023 - 01/2021
5	Rhinosinusitis 01/2023 - 06/2015
5	Carcinogenesis 01/2022 - 01/2015
5	Retinal Detachment (Retinal Detachments) 08/2020 - 04/2013
5	Hepatocellular Carcinoma (Hepatoma) 10/2015 - 02/2014
4	Ganglion Cysts (Ganglion) 01/2024 - 06/2015
4	Fatigue 01/2023 - 08/2021
4	Hypertrophy 01/2023 - 12/2009
4	COVID-19 12/2022 - 01/2021
4	Hypertension (High Blood Pressure) 04/2021 - 09/2005
4	Liver Cirrhosis (Hepatic Cirrhosis) 12/2012 - 02/2012
4	Macular Edema 07/2008 - 12/2003
3	Pituitary Neoplasms (Pituitary Adenoma) 12/2022 - 03/2013
3	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 08/2022 - 01/2018
3	Infarction (Infarctions) 01/2022 - 01/2019
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2015
3	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2020 - 06/2013
3	Ventricular Remodeling 12/2019 - 07/2011
3	B-Cell Lymphoma (Lymphoma, B Cell) 10/2019 - 01/2015
2	Optic Neuritis (Retrobulbar Neuritis) 01/2024 - 02/2023
2	Obesity 12/2023 - 04/2021
2	Multiple Myeloma 11/2023 - 01/2023
2	Alzheimer Disease (Alzheimer's Disease) 11/2023 - 01/2022
2	Wounds and Injuries (Trauma) 05/2023 - 09/2011
2	Adenocarcinoma of Lung 01/2023 - 01/2021
2	Atrophy 01/2023 - 12/2009
2	Fever (Fevers) 01/2023 - 01/2021
2	Respiratory Tract Infections (Respiratory Tract Infection) 12/2022 - 03/2022
2	Acromegaly 10/2022 - 01/2018

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 11/2023 - 11/2006
19	Retinaldehyde (Retinal)IBA 01/2024 - 12/2003
15	CytokinesIBA 07/2022 - 12/2008
14	Messenger RNA (mRNA)IBA 01/2022 - 12/2008
11	CollagenIBA 04/2024 - 01/2012
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2014
8	Capsules (Microcapsules)IBA 07/2022 - 01/2018
7	ChemokinesIBA 01/2020 - 12/2011
6	LigandsIBA 11/2019 - 01/2014
5	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2014
5	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2021
5	Connexin 43 (Connexin43)IBA 07/2022 - 01/2018
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 11/2011
4	AntioxidantsIBA 02/2024 - 01/2018
4	MicroRNAs (MicroRNA)IBA 02/2023 - 01/2014
4	Interleukin-10 (Interleukin 10)IBA 12/2022 - 11/2018
4	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 11/2011
4	Streptozocin (Streptozotocin)FDA Link 01/2020 - 01/2014
4	HMGB1 Protein (HMG1)IBA 01/2020 - 11/2010
4	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2015 - 12/2011
3	Fatty Acids (Saturated Fatty Acids)IBA 04/2024 - 01/2021
3	Indicators and Reagents (Reagents)IBA 01/2024 - 08/2021
3	Oxygen (Dioxygen)IBA 01/2023 - 07/2012
3	Interleukin-8 (Interleukin 8)IBA 12/2022 - 01/2021
3	InterleukinsIBA 12/2022 - 06/2015
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 01/2020
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 06/2015
3	Peptides (Polypeptides)IBA 01/2022 - 10/2015
3	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 01/2015
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021 - 01/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2018 - 04/2015
3	NanocapsulesIBA 01/2018 - 07/2016
3	CurcuminIBA 05/2017 - 06/2012
3	Platelet-Derived Growth FactorIBA 06/2015 - 04/2012
3	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2012 - 02/2012
2	Cisplatin (Platino)FDA LinkGeneric 04/2024 - 10/2015
2	LipidsIBA 04/2024 - 11/2020
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2024 - 01/2024
2	NS 1619IBA 02/2024 - 06/2011
2	Mitochondrial DNA (mtDNA)IBA 12/2023 - 03/2023
2	AcidsIBA 11/2023 - 12/2018
2	CarbonIBA 11/2023 - 12/2018
2	DNA (Deoxyribonucleic Acid)IBA 03/2023 - 01/2021
2	Volatile Fatty AcidsIBA 01/2023 - 01/2020
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2023 - 01/2021
2	Growth Hormone (Somatotropin)IBA 10/2022 - 03/2013
2	Insulin-Like Growth Factor I (IGF-1)IBA 10/2022 - 01/2018

Therapy/Procedure

16	Therapeutics 02/2024 - 06/2002
8	Vitrectomy 08/2020 - 05/2004
7	Drug Therapy (Chemotherapy) 04/2024 - 04/2015
5	Thrombectomy 02/2024 - 01/2022
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2021 - 01/2018
3	Lung Transplantation 01/2024 - 01/2023
3	Acupuncture Therapy 12/2012 - 02/2012
2	Percutaneous Coronary Intervention 10/2023 - 03/2014
2	Anesthesia 09/2023 - 06/2002